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Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel human coronavirus
that emerged in 2012, causing severe pneumonia and acute respiratory distress syndrome
(ARDS), with a case fatality rate of ~36%. When expressed in isolation, CoV accessory pro-
teins have been shown to interfere with innate antiviral signaling pathways. However, there
is limited information on the specific contribution of MERS-CoV accessory protein 4b to the
repression of the innate antiviral response in the context of infection. We found that MERS-
CoV 4b was required to prevent a robust NF-κB dependent response during infection. In
wild-type virus infected cells, 4b localized to the nucleus, while NF-κB was retained in the
cytoplasm. In contrast, in the absence of 4b or in the presence of cytoplasmic 4b mutants
lacking a nuclear localization signal (NLS), NF-κB was translocated to the nucleus leading
to the expression of pro-inflammatory cytokines. This indicates that NF-κB repression
required the nuclear import of 4b mediated by a specific NLS. Interestingly, we also found
that both in isolation and during infection, 4b interacted with α-karyopherin proteins in an
NLS-dependent manner. In particular, 4b had a strong preference for binding karyopherin-
α4 (KPNA4), which is known to translocate the NF-κB protein complex into the nucleus.
Binding of 4b to KPNA4 during infection inhibited its interaction with NF-κB-p65 subunit.
Thereby we propose a model where 4b outcompetes NF-κB for KPNA4 binding and translo-
cation into the nucleus as a mechanism of interference with the NF-κB-mediated innate
immune response.
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Author summary
Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic
human CoV that continues to cause lethal human infections, primarily in the Middle
East. Virus accessory genes are potential contributors to pathology, possibly by interfering
with the innate immune response. However, understanding their interactions with host
proteins in the context of infection is rudimentary. Here, we provide evidence that the
MERS-CoV accessory protein 4b functioned, at least in part, to prevent a robust NF-κB
dependent response during infection. This effect depended on the nuclear localization of
4b, which was associated with the cytoplasmic retention of NF-κB. We show that 4b inter-
acted with α-karyopherin proteins (importins) involved in the nuclear import of NF-κB,
inhibiting the binding of α-karyopherin to NF-κB-p65 subunit. We propose that 4b con-
tributes to the evasion of the innate immune response by binding α-karyopherin proteins,
leading to the inhibition of NF-κB nuclear transport.
Introduction
Middle East respiratory syndrome coronavirus (MERS-CoV) is a human coronavirus that
emerged in the Middle East in 2012. Since then, 2100 confirmed cases and 730 deaths have
been reported, with an estimated mortality rate of ~36% (http://www.who.int/csr/don/
10-november-2017-mers-oman/en/). Currently, MERS-CoV remains a public health threat, as
new infections continue to occur and no approved vaccines or antivirals are available. Further-
more, MERS-CoV is endemic in camels, making it likely that the virus will be an ongoing con-
cern. Evidence from a number of studies has demonstrated that MERS-CoV strongly inhibits
IFN-α/β production [1–3], although our knowledge on how the virus interferes with the host
antiviral response is still limited. The contribution of viral proteins to the inhibition of the
innate antiviral and pro-inflammatory responses has been mainly addressed in cells overex-
pressing individual viral proteins, not in the context of virus infection.
The nuclear factor-κB (NF-κB) family of proteins are critical regulators of both innate and
adaptive immunity [4]. In naïve cells, NF-κB proteins are present in the cytoplasm in associa-
tion with inhibitory proteins (IκBs). Cellular stimuli, including pathogens and stress, induce
IκB phosphorylation, ubiquitination and degradation by the proteasome, releasing NF-κB pro-
teins and allowing their nuclear translocation. In the nucleus, NF-κB proteins promote the
transcription of pro-inflammatory cytokines and chemokines, stress-response proteins, and
anti-apoptotic proteins. NF-κB activity is essential for lymphocyte survival and activation, and
for initiating and propagating optimal immune responses. By contrast, the constitutive activa-
tion of the NF-κB pathway is often associated with inflammatory diseases, such as rheumatoid
arthritis and asthma. Exacerbated NF-κB activity has been demonstrated to be important for
the inflammatory immunopathology induced by respiratory viruses such as severe acute respi-
ratory syndrome (SARS)-CoV [5, 6] and influenza A virus [7]. Here, we found that nuclear
MERS-CoV 4b protein contributes to the inhibition of the host NF-κB-mediated pro-inflam-
matory response by preventing the nuclear translocation of NF-κB. In addition, we identified
karyopherin-α4 (importin-α3), which is responsible for the nuclear import of NF-κB, as a 4b
binding protein. We found that 4b binding to karyopherin-α4 inhibited its interaction with
NF-κB-p65 subunit, thus preventing NF-κB nuclear translocation and, as a consequence,
expression of NF-κB-dependent pro-inflammatory cytokines during infection. The ability of
4b to block NF-κB is likely to be relevant for MERS-CoV-induced in vivo pathology and
virulence.
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Results
Identification of MERS-CoV accessory genes that interfere with the innate
immune response during infection
To address whether MERS-CoV accessory genes 3, 4a, 4b or 5 interfere with the innate
immune response during infection, we infected Huh-7 cells with previously engineered
MERS-CoV deletion mutants (Δ3, Δ4ab, Δ5) [8] and analyzed the expression of interferon β
(IFN-β) and the pro-inflammatory cytokines IL-6, IL-8, and TNF-α. Viruses deleted in the
accessory proteins, like the parental virus [3], were unable to induce IFN (S1 Fig) in contrast to
the effective induction of IFN-β by poly(I:C) transfection, implying that additional proteins
expressed by the virus act as IFN antagonists [9]. Interestingly, dual deletion of genes 4a and
4b led to a significant increase in the expression levels of IL-6, IL-8, and TNF-α as compared
to the wild-type infection (S1 Fig). Since the transcription of these genes depends on NF-κB
[4], these results suggested that one or both proteins repressed NF-κB activation during
MERS-CoV infection.
Contribution of MERS-CoV 4a and 4b proteins to the inhibition of NF-κB
activity
In order to determine the specific contribution of 4a and 4b proteins to the inhibition of the
NF-κB response during infection, individual deletion mutants MERS-CoV-Δ4a and MERS-
CoV-Δ4b were engineered (Fig 1A). The 4a and 4b genes have overlapping coding sequences
and are expressed from the same subgenomic mRNA, and thus 4b is likely expressed by either
internal ribosomal entry or “leaky scanning” of ribosomes [10]. The 4a deletion preserved the
transcription-regulating sequences (TRS) preceding 4a gene, which comprise the conserved
sequence (CS), and 26 nt downstream of the CS, including the first 22 nt of ORF 4a. In addition,
the 3’ 101 nt of the 4a gene preceding ORF 4b were maintained in order to preserve translation
of 4b protein, as suggested for other CoV ORFs that are translated by similar mechanisms [11].
In the case of MERS-CoV-Δ4b the 4b gene was almost entirely deleted excluding the 4a/4b over-
lapping sequences and the 3’ most 53 nt, in order to maintain the TRS for transcription of gene 5
(Fig 1A). MERS-CoV-Δ4a and MERS-CoV-Δ4b were recovered from plasmids pBAC-MERSFL-
Δ4a and pBAC-MERSFL-Δ4b, respectively, in Huh-7 cells with titers similar to those of wild-type
virus. After two passages in cell culture, the recombinant viruses were sequenced to confirm
their stability. The replication kinetics of these singly mutated viruses in Huh-7 cells was not sig-
nificantly different from that of the wild-type virus (Fig 1B), with only a slight decrease in titers
at some time points. These results confirm that proteins 4a and 4b were not required for virus
replication in cell culture [8]. The presence or absence of 4b and 4a proteins in Huh-7 cells
infected with the recombinant viruses MERS-CoV-Δ4a, MERS-CoV-Δ4b and MERS-CoV-Δ4ab
was confirmed by Western-blot and immunofluorescence assays. The expression levels of 4a and
4b proteins (A in S2 Fig) and their subcellular distribution (B and C in S2 Fig) were similar to
those of the wild-type virus, indicating that 4a and 4b gene expression was not affected in the
deletion mutants. While 4a protein showed a cytoplasmic distribution [9, 12, 13] partially coloca-
lizing with viral dsRNA, 4b protein localized to the nucleus of infected cells, as previously
described [10].
The expression of mRNAs coding for NF-κB-dependent pro-inflammatory cytokines was
analyzed in Huh-7 cells infected with the deletion mutants Δ4a and Δ4b at a multiplicity of
infection (MOI) of 1 PFU/cell (Fig 1C). While deletion of 4a did not have any effect on the
expression of IL-6, IL-8 and TNF-α as compared to the wild-type virus, deletion of 4b signifi-
cantly increased their expression to similar or even higher levels than those observed in
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MERS-CoV-Δ4ab, indicating that the 4b protein contributed to the repression of NF-κB-
dependent gene expression.
Fig 1. Generation of MERS-CoV-Δ4a and Δ4b deletion mutants. (A) Schematic representation of MERS-CoV WT
genome. Essential viral genes (ORF1a, ORF1b, S, E, M, N) and accessory genes (3, 4a, 4b and 5) are indicated. L, leader
sequence; An, poly(A) tail; CS, conserved sequence included in transcription-regulating sequences. Genes 4a and 4b
were deleted from the MERS-CoV infectious cDNA clone by PCR-directed mutagenesis as described in Materials and
Methods. Deleted regions within 4a and 4b genes are illustrated as light grey boxes. The size of both deleted and
remaining regions in 4a and 4b genes is indicated by arrows. The patterned boxes in Δ4a and Δ4b mutants indicate
frameshift mutations in 4a and 4b sequence caused by the deletions. (B) Growth kinetics of Δ4a and Δ4b deletion
mutants in Huh-7 cells at the indicated MOIs. Supernatants were collected at 24, 48 and 72 hpi and titrated by plaque
assay. (C) NF-κB-dependent cytokine response of Huh-7 cells either mock-infected or infected with WT, Δ4ab, Δ4a or
Δ4b mutants (MOI = 1 PFU/cell). At 24 hpi, mRNA levels of IL-6, IL-8 and TNF-α were quantified by RT-qPCR and
compared to those in WT-infected cells, using the ΔΔCt method for calculation and HMBS as a reference endogenous
gene. Shown are means with standard deviations, which were analyzed using an unpaired t-test against the wild-type
(, p<0.01; , p<0.001).
https://doi.org/10.1371/journal.ppat.1006838.g001
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Engineering recombinant MERS-CoVs with mutations in 4b nuclear
localization signals (NLS)
To determine whether import of 4b protein into the nucleus was required for interference
with the NF-κB pathway, MERS-CoV mutants defective in 4b nuclear localization were engi-
neered (Fig 2A). MERS-CoV 4b protein includes a bipartite NLS consisting of two triplets of
positively charged amino acids [10], named site 1 (NLS-S1) and site 2 (NLS-S2) (Fig 2A).
Mutation of NLS-S1 in the context of 4b overexpression completely prevented nuclear import,
while mutation of NLS-S2 only partially hindered nuclear localization of 4b [10]. Two conse-
cutive lysine residues located between NLS-S1 and NLS-S2 might also contribute to the nuclear
localization of 4b, and were included in our mutagenic analysis.
Since the 4b NLS-S1 is located within the 4a/4b overlapping sequence, its mutagenesis
required the separation of 4a and 4b genes by duplicating the common region. A recombinant
MERS-CoV-DUP cDNA with a 189 nt duplication including the 4a/4b overlapping sequences
(88 bp) and 4a preceding sequences (101 bp), likely required for 4b translation, was generated
as a control (DUP, Fig 2A). Two mutant MERS-CoV cDNAs including the 4a/4b duplication
were then engineered either containing alanine mutations of NLS-S1 (RKR!AAA, MERS-
CoV-DUP-mNLS-S1), or both the intermediate Lys residues and NLS-S2 (KK!AA and
KRR!AAA, MERS-CoV-DUP-mNLS-S2). Recombinant viruses were rescued from infec-
tious cDNAs in Huh-7 cells and the expression of 4a and 4b proteins was characterized. No
significant differences in the expression levels of 4a and 4b proteins in Huh-7 cells were
observed by Western-blot analysis, as compared to the wild-type virus (A in S3 Fig), confirm-
ing that genome engineering of 4b NLS mutants did not affect virus gene expression. Accord-
ingly, the cytoplasmic distribution of 4a protein observed in MERS-CoV-wild-type-infected
cells was not affected in the NLS mutants (B in S3 Fig). Analysis by confocal microscopy of 4b
subcellular localization (Fig 2B) confirmed that 4b protein was mostly detected in the nucleus in
MERS-CoV-DUP-infected cells, as observed in cells infected with wild-type virus. In contrast,
mutation of 4b NLS-S1 in MERS-CoV-DUP-mNLS-S1 prevented the nuclear localization of 4b,
which was mainly restricted to the cytoplasm. Mutation of NLS-S2 in MERS-CoV-DUP-mNLS-S2
only partially prevented the nuclear import of 4b, with protein detected in both the nucleus and the
cytoplasm. These results demonstrated that in the context of infection, 4b NLS-S1 was essential for
nuclear localization, while NLS-S2 had only a partial effect on 4b nuclear import, as described in 4b
overexpression experiments [10]. The growth kinetics of MERS-CoV NLS mutants in Huh-7 and
Calu-3 (a bronchial epithelial cell line) cells (Fig 2C and C in S3 Fig) confirmed that neither the
duplication of 4a-4b sequences nor the mutation of 4b NLS-S1 or NLS-S2 affected viral replication
as compared to the wild-type virus. This indicates that the nuclear localization of 4b protein during
infection did not have a significant impact on virus replication in cell culture.
The NLS sequences of 4b are required for the repression of NF-κB-
dependent pro-inflammatory cytokine expression during infection
To evaluate the relevance of 4b nuclear localization in the antagonism of the innate immune
response during infection, Huh-7 and Calu-3 cells were infected with 4b-NLS mutants at a
MOI of 1 PFU/cell. The expression of NF-κB-mediated pro-inflammatory cytokines IL-6, IL-8
and TNF-α was analyzed by RT-qPCR at 24 hpi (Fig 3A–3C). Mutation of NLS-S1 led to sig-
nificantly elevated expression levels of NF-κB dependent pro-inflammatory cytokines, similar
to those induced by MERS-CoV-Δ4b. Mutation of NLS-S2, leading to a partially nuclear 4b
protein, increased the expression of pro-inflammatory cytokines to intermediate levels as com-
pared to the NLS-S1 mutation. These results indicated that nuclear translocation of 4b was
required to inhibit the expression of NF-κB dependent pro-inflammatory cytokines both in
NF-κB inhibition by MERS-CoV 4b protein during infection
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Fig 2. Generation of MERS-CoV-4b-NLS mutants. (A) Schematic representation of 4a and 4b overlapping sequences
in MERS-CoV WT (top) and 4b-NLS mutants (bottom). Nuclear localization signals in 4b protein (NLS-S1 and
NLS-S2), consisting of positively charged amino acids lysine (K) and arginine (R) are indicated. The 189 nt-sequence
duplicated in 4b-NLS mutants is indicated by the shadowed area and the arrows. DUP, mutant including WT
duplicated 4a-4b sequences, used as a control; DUP-mNLS-S1, mutant with 4b NLS Site 1 mutated to alanine; DUP-
mNLS-S2, mutant with Site 2 and two close Lys residues mutated to alanine, as described in Materials and Methods.
The light blue boxes in DUP, DUP-mNLS-S1 and DUP-mNLS-S2 mutants indicate duplicated 4a sequences. PacI and
NheI restriction sites used for the assembly of infectious cDNA clones and their genomic positions (first nucleotide of
the recognition sequence) are indicated. (B) Analysis by confocal microscopy of 4b subcellular localization in Huh-7
cells either mock-infected or infected with MERS-CoV-4b-NLS mutants (MOI = 0.1 PFU/cell, 24 hpi). 4b protein
(green) and dsRNA (red) were detected with specific antibodies, while nuclei (blue) were stained with DAPI. (C)
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Huh-7 and Calu-3 cells, suggesting that this effect might be relevant in the natural infection.
Thus, MERS-CoV infection induced an NF-κB-dependent response either in the absence of 4b
or in the presence of 4b proteins deficient in nuclear localization.
MERS-CoV infection of Calu-3 cells in the absence of 4b protein only led to a two-fold
increase in IFN-β levels, while no difference in IFN-β levels was observed in Huh-7 cells. This
is in contrast to the high expression levels induced by the positive control poly(I:C) (Fig 3C).
4b NLS mutants did not induce IFN-β production in Calu-3 cells, suggesting a limited contri-
bution of 4b protein to the suppression of the IFN-β response and confirming the idea that
multiple viral proteins participate in the antagonism of the innate immune response.
Effect of 4b-NLS mutations in the NF-κB signaling pathway during
MERS-CoV infection
To confirm that the pro-inflammatory response induced by MERS-CoV in the absence of
nuclear 4b protein was mediated by NF-κB, Huh-7 cells were treated with the NF-κB inhibitor
parthenolide [14] at the same time cells were infected. Parthenolide treatment inhibited the
expression of NF-κB dependent pro-inflammatory cytokines induced by 4b mutant viruses
without affecting virus production (Fig 3A and 3B). This confirmed that NF-κB mediated the
pro-inflammatory response observed in 4b-mutant virus infected cells.
To determine the step in the NF-κB signaling pathway targeted by 4b protein, the amount of
NF-κB p65 subunit was first analyzed by Western-blot in cells infected with 4b-mutant MERS-
CoVs. No differences in p65 levels were observed among MERS-CoV mutants regardless of the
NF-κB-mediated response (Fig 3D). Since activation of NF-κB requires the degradation of the
inhibitor IκBα, levels of IκBα were analyzed by Western-blot in cells infected with 4b-mutant
MERS-CoVs (A in S4 Fig). It was difficult to detect IκBα degradation in the context of viral
infection, most likely indicating that activation of the pathway was not complete. Alternatively,
activated NF-κB has been reported to rapidly induce expression of IκBα to restore NF-κB inhi-
bition [15]. To examine the impact of viral infection on IκBα degradation, we further treated
infected cells with TNF-α for different time periods at 14 hours post-infection, which is
expected to induce a sustained reduction in IκBα levels. At this time point, significant levels of
4b had accumulated (B in S4 Fig), providing a scenario where we could evaluate potential inhi-
bition of IκBα degradation by 4b. Degradation of IκBα in infected cells treated with TNF-α was
associated with induction of pro-inflammatory mRNAs, thus confirming that TNF-α activated
the NF-κB pathway (C in S4 Fig). Furthermore, 4b protein significantly reduced the expression
levels of pro-inflammatory cytokines induced by TNF-α in infected cells as compared to infec-
tion with Δ4b virus, reinforcing the potential of 4b protein to repress the NF-κB response (C
in S4 Fig). However, no differences in IκBα levels were observed in infections with Δ4b and 4b
NLS-mutant MERS-CoVs after TNF-α stimulation, suggesting that the 4b protein did not
inhibit the degradation of IκBα (Fig 3E and A in S4 Fig). Together, these results indicated that
inhibition of the NF-κB response by the 4b protein did not occur at steps prior to the nuclear
translocation of NF-κB.
MERS-CoV 4b protein interacts with α-karyopherins
In a co-immunopecipitation (Co-IP) mass spectrometry screen for 4b interacting partners, we
identified several peptides corresponding to karyopherin (KPNA)-α4 and KPNA-α3 (also
Growth kinetics of MERS-CoV-4b-NLS mutants in Huh-7 and Calu-3 cells at an MOI of 0.1. Supernatants were
collected at 24, 48 and 72 hpi and titrated by plaque assay. Error bars represent SD.
https://doi.org/10.1371/journal.ppat.1006838.g002
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Fig 3. NF-κB-dependent cytokine response during infection with MERS-CoV-4b-NLS mutants (MOI = 1 PFU/
cell, 24 hpi). (A) The mRNA expression levels of IL-6, IL-8 and TNF-α were quantified by RT-qPCR in Huh-7 cells
either mock-treated or treated with the NF-κB inhibitor parthenolide (12 μM), as described in Fig 1. Error bars
represent SD. (B) Viral titers in the supernatant of Huh-7 cells infected with MERS-CoV-4b-NLS mutants either
mock-treated or treated with parthenolide. (C) The mRNA expression levels of IL6, IL8, TNF-α and IFNB1 were
quantified by RT-qPCR in Calu-3 cells infected with MERS-CoV-4b-NLS mutants as described in S1 Fig. (D) Analysis
by Western-blot of NF-κB p65 levels at 24 hpi in Huh-7 cells infected with 4b-NLS mutants (MOI = 1 PFU/cell). (E)
Analysis by Western-blot of TNF-α induced IκBα degradation in Huh-7 cells either mock-infected or infected with
MERS.CoV-4b-NLS mutants (MOI = 1 PFU/cell). At 14 hpi, cell supernatant was replaced by fresh medium
containing TNF-α (50 ng/ml). After 30 min treatment, cell lysates were prepared for immunoblotting with anti IκBα
antibody. Actin was used as a loading control. Shown are means with standard deviations, which were analyzed using
an unpaired t-test against the wild-type (, p<0.1; p<0.01; , p<0.001).
https://doi.org/10.1371/journal.ppat.1006838.g003
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known as importin-α3 and importin-α4, respectively) that were immunoprecipitated with
overexpressed 4b-FLAG protein but not the SARS-CoV control protein nsp15-FLAG (S5 Fig).
These interactions were confirmed by reciprocal co-immunoprecipitation experiments fol-
lowed by Western blotting (Fig 4A and 4B). Specifically, pull-down of 4b-FLAG from Huh-7
cells with a FLAG antibody isolated endogenous karyopherin-α4 and karyopherin-α3, but
not the control protein actin (Fig 4A). Conversely, pull-down of overexpressed KPNA4-FLAG
in Huh-7 cells with FLAG antibody isolated the co-expressed 4b-HA protein but not the 4a-
HA protein (Fig 4B). To confirm that 4b interacts with KPNA4 in the context of infection,
KPNA4-FLAG or control GFP expressing plasmids were transfected into Huh-7 cells, prior to
infection with wild-type virus. At 20 hpi, the cell lysates were immunoprecipitated with FLAG
Fig 4. MERS-CoV 4b protein interacts with importin-α2 family karyopherins. (A-B). 4b interacts with KPNA3 and
KPNA4 when expressed in isolation. Huh-7 cells were transfected with plasmids expressing NSP15-3XFLAG or 4b-
3XFLAG (A) or KPNA4-FLAG and 4a-HA or 4b-HA (B). Cells were collected 48 hours later and cell lysates were
immunoprecipitated with anti-FLAG monoclonal antibody. Cell lysates (CL) and eluted proteins were analyzed by
immunoblotting with indicated antibodies. (C) 4b interacts with KPNA4 during infection. Huh-7 cells were
transfected with plasmids expressing GFP or KPNA4-FLAG (K4-FL). 48 hours later cells were infected with
MERS-CoV at an MOI of 0.1 PFU/cell. Cells were collected at 20 hpi and cell lysates were immunoprecipitated and
analyzed as described above. (D) 4b requires both NLS Site 1 and Site 2 for efficient interaction with KPNA4. Huh-7
cells were transfected with plasmids expressing sMacro-3XFLAG (C-), 4b-3XFLAG (4b), or the 4b-NLS mutants 4b-
mNLS-S1–3XFLAG (NLS-S1), or 4b-mNLS-S2–3XFLAG (NLS-S2). Cells were collected 48 hours later and cell lysates
were immunoprecipitated and analyzed as described above. Viral protein 4a and cell proteins actin and GAPDH have
been used as controls for non-specific binding to KPNA4-FLAG or to FLAG-antibody coated beads. GFP has been
used as a control for 4b non-nonspecific binding to the FLAG-antibody coated beads in the absence of karyopherin
protein.
https://doi.org/10.1371/journal.ppat.1006838.g004
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antibody followed by Western-blot analysis for either endogenous 4b or 4a proteins (Fig 4C).
Significant amounts of 4b but not 4a protein were isolated with KPNA4-FLAG but not GFP
expressing cells, indicating a strong and specific interaction.
The nuclear translocation of most cellular proteins is mediated by α-karyopherins (or
importin-αs), which directly bind the NLS within cargo proteins, and karyopherin-β (or
importin-β). The latter interacts with nucleoporins to promote nuclear import [16]. Since
MERS-CoV 4b protein includes a bipartite NLS and localizes to the nucleus during infection,
we tested whether the bipartite NLS sequences of 4b were required for KPNA4 binding. The
basic amino acids in NLS-S1 or NLS-S2 were replaced with alanine in plasmids (4b-mNLS-
S1–FLAG or 4b-mNLS-S2–FLAG) and subsequently transfected into Huh-7 cells. Cell lysates
were analyzed by co-immunoprecipitation with FLAG antibodies followed by Western-blot
(Fig 4D). Endogenous KPNA4 did not co-immunoprecipitate with 4b proteins mutated either
in NLS-S1 or NLS-S2, in contrast to wild-type 4b protein. This indicates that MERS-CoV 4b
protein requires both NLS-S1 and NLS-S2 for efficient interaction with KPNA4. It also strong-
ly suggests that 4b interacts with KPNA4 as a mechanism to enter the nucleus.
The α-karyopherins are divided into 3 sub-families. The importin-α1 subfamily, consisting
of KPNA2 and KPNA7, are general importers of cargo that bear a classic NLS; the importin-
α2 subfamily, consisting of KPNA4 and KPNA3, are known for their specificity for NF-κB and
the regulator of chromosome condensation (RCC)-1; and finally the importin-α3 subfamily,
consisting of KPNA1, KPNA5, and KPNA6, is best known for binding phosphorylated STATs
as well as several Influenza A virus proteins and Ebola virus VP24 [17]. In our screen, 4b pro-
tein only pulled down importin-α2 subfamily members (S5 Fig), which are known to bind
NF-κB. To directly test whether 4b preferentially interacted with importin-α2 subfamily pro-
teins, we analyzed the ability of 4b protein to interact with α-karyopherins of each subfamily.
KPNA1 (importin-α3 subfamily), KPNA2 (importin-α1 subfamily), and KPNA3 and KPNA4
(importin-α2 subfamily) were expressed as KPNA-FLAG fusion proteins in Huh-7 cells along
with HA-tagged 4b protein. Cells were collected 48 hours post-transfection and cell lysates
were immunoprecipitated with an anti-FLAG monoclonal antibody. The presence of KPNA
and 4b protein was detected by Western-blot with anti-FLAG and anti-HA antibodies, respec-
tively (Fig 5A). Quantification of relative binding to each karyopherin (Fig 5B) showed that 4b
protein preferentially bound to KPNA4, and to a lesser extent, KPNA3. Binding of 4b protein
to karyopherin-α family members during infection was assayed in a similar fashion. Huh-7
cells were transfected with plasmids expressing KPNA-FLAG fusion proteins and infected 48
hours later with wild-type MERS-CoV at an MOI of 0.1 PFU/cell. Cells were collected at 20
hpi and cell lysates were immunoprecipitated with an anti-FLAG antibody and analyzed with
anti-4b and anti-FLAG antibodies (Fig 5C). In the context of infection, MERS-CoV 4b protein
also preferentially bound to KPNA4 over all other karyopherins, including KPNA3 (Fig 5C
and 5D). However, 4b could at least minimally bind to other KPNAs, possibly explaining the
ability of 4b-mNLS-S2 to partially access the nucleus. The favorable interaction between 4b
and KPNA4 is consistent with the idea that 4b prevented the nuclear import of NF-κB by bind-
ing to KPNA4 [18].
MERS-CoV 4b protein inhibits the nuclear translocation of NF-κB in the
context of infection
Together, the above-mentioned results indicated that 4b protein specifically bound to KPNA4
both in the absence and in the presence of infection. Additionally, during MERS-CoV infec-
tion, the expression of pro-inflammatory cytokines was inhibited in the presence of wild-type
nuclear 4b protein, in contrast to 4b cytoplasmic mutants. Therefore, we hypothesized that in
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infected cells, wild type 4b protein would interfere with NF-κB nuclear translocation. To test
this possibility, we analyzed the nuclear-cytoplasmic distribution of 4b and the NF-κB p65
subunit at 24 hpi in Huh-7 and Calu-3 cells infected at an MOI of 0.1 PFU/cell either with
wild-type MERS-CoV or with MERS-CoV recombinant viruses expressing cytoplasmic 4b-
NLS mutant proteins. Western blot analysis of nuclear and cytoplasmic fractions and confocal
microscopy analysis showed that during infection with the control viruses, MERS-CoV-wild-
type or DUP, 4b protein mainly localized to the nucleus while most of the p65 protein was
detected in the cytoplasm (Fig 6A–6C and S6 Fig). In contrast, in infections either with
MERS-CoV-Δ4b or MERS-CoV-DUP-mNLS-S1, p65 was detected both in the nucleus and
the cytoplasm. In MERS-CoV-DUP-mNLS-S2 infection, the dual distribution of 4b protein
between the nucleus and the cytoplasm was associated with the presence of p65 in both cellular
compartments. This observation suggested that partial access to the nucleus of 4b-mNLS-S2
was enough to allow a significant increase in p65 nuclear import as compared to that observed
Fig 5. MERS-CoV 4b has higher affinity for interaction with karyopherin-α4 than other karyopherins. (A) Huh-7
cells were co-transfected with plasmids expressing 4b-HA and empty vector (EV) or Control-3XFLAG (C-) or KPNA-
FLAG proteins KPNA1-FLAG (K1), KPNA2-FLAG (K2), KPNA3-FLAG (K3), or KPNA4-FLAG (K4). Cells were
collected 48 hours later and cell lysates (CL) were immunoprecipitated with anti-FLAG monoclonal antibody. Cell
lysates and eluted proteins were analyzed by immunoblotting with indicated antibodies. (B) Quantification of 4b-
karyopherin interactions. The relative binding of 4b to each karyopherin was determined by measuring the HA signal
and dividing by the FLAG signal, derived using Image Studio Software. The ratio of 4b-HA to KPNA1-FLAG was set to
1. Data represent the combined results of 2 independent experiments. Error bars represent SD. (C) Huh-7 cells were
transfected with plasmids expressing GFP-3XFLAG (C-) or KPNA-FLAG proteins KPNA1-FL (K1), KPNA2-FL (K2),
KPNA3-FL (K3), or KPNA4-FL (K4). 48 hours later, cells were infected with WT MERS-CoV at a MOI of 0.1 PFU/cell.
Cells were collected at 20 hpi and cell lysates were immunoprecipitated with anti-FLAG monoclonal antibody and
analyzed as described in (A). Cell protein RuvBL1 has been used as a control for non-specific binding to KPNA4-FLAG
or to FLAG-antibody coated beads. GFP and C- have been used as controls for 4b non-nonspecific binding to the
FLAG-antibody coated beads in the absence of karyopherin protein. (D) The relative binding of 4b to each karyopherin
during infection was determined as described in (B). These data represent the combined results of 2 independent
experiments. Error bars represent SD.
https://doi.org/10.1371/journal.ppat.1006838.g005
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Fig 6. Subcellular localization of NF-κB during infection with MERS-CoV 4b-NLS mutants. Huh-7 (A) or Calu-3 (B) cells were
mock-infected or infected (MOI = 0.1 PFU/cell) with WT, Δ4b or 4b-NLS mutants. At 18 hpi, cells were fractionated into cytoplasmic
(C) and nuclear (N) fractions and analyzed by Western-blot for 4b and p65 detection. GAPDH and histone H3 were used as
cytoplasmic and nuclear markers, respectively. Huh-7 (C) or Calu-3 (D) cells were infected with WT, Δ4b or 4b-NLS mutants (MOI
0.1 PFU/cell). At 24 hpi, cells were fixed and stained with antibodies against 4b (green) and p65 (red). Cell nuclei were stained with
DAPI (blue).
https://doi.org/10.1371/journal.ppat.1006838.g006
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in the presence of nuclear wild-type 4b protein. Together, these results indicated that 4b pro-
tein with an intact NLS prevented nuclear import of NF-κB in Huh-7 cells and in the physio-
logically relevant Calu-3 cells, suggesting that this mechanism might also be critical in a
natural lung infection.
Since KPNA4 binds both p65 [18] and 4b (Fig 4D) proteins through their NLS sequences, it
is conceivable that 4b and p65 compete for binding to the same site in KPNA4. To address this
question, co-IP experiments with FLAG antibodies in Huh-7 cells transfected with a KPNA4-
FLAG plasmid and infected with MERS-CoVs expressing 4b-NLS mutant proteins were per-
formed. These results confirmed that binding of KPNA4 to 4b protein was also NLS-depen-
dent in the context of infection (Fig 7). Interestingly, in wild-type MERS-CoV-infected cells,
immunoprecipitation of KPNA4 did not pull-down p65 while it did it in Δ4b and 4b NLS
mutant virus infected cells. Together, these results strongly suggest that 4b interacts with
KPNA4 in a NLS-dependent manner as a mechanism to gain entry into the nucleus, leading to
the inhibition of p65 nuclear import by KPNA4.
Discussion
MERS-CoV strongly represses the innate immune response [1], although the specific factors
that contribute to this repression during infection are unknown. To date, all studies involving
MERS-CoV proteins and their interactions with the innate immune response have been done
with viral proteins expressed in isolation [10, 12, 13, 19, 20]. These studies can give a glimpse
into the mechanisms used by the virus to block interferon and other innate immune factors.
However, proteins expressed in isolation may not function as they do in the context of an
infection, due to excessive protein production, improper localization, or the presence/absence
of specific cellular or viral proteins [21]. Previous reports indicated that when expressed in iso-
lation, 4b blocked IFN expression induced by Sendai virus (SeV) or by overexpression of cellu-
lar factors that function in the IFN-induction pathways [20]. Inhibition of IRF-3 or IRF-
Fig 7. Interference of MERS-CoV 4b protein in NF-κB-karyopherin 4 binding during infection. Huh-7 cells were
transfected with a plasmid encoding karyopherin 4 (KPNA4)-FLAG. At 24 hpt, cells were infected (MOI 0.1 PFU/cell)
with WT, Δ4b or 4b-NLS mutants. At 20 hpi, cells lysates were immunoprecipitated with anti-FLAG antibodies. Cell
lysates (CL) and eluted proteins were analyzed by immunoblotting with indicated antibodies.
https://doi.org/10.1371/journal.ppat.1006838.g007
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7-induced IFN production required the NLS sequences of 4b, whereas deletion of 4b NLS did
not affect IFN expression induced by other factors such as MDA5, MAVS, IKKε and TBK-1.
These results suggested that 4b could inhibit the induction of IFN-β in both the nucleus and
the cytoplasm. Here, we show that MERS-CoV-Δ4b infection did not induce IFN in Huh-7
cells, while a limited IFN response was observed in Calu-3 cells, suggesting that additional
mechanisms independent of 4b expression are used by MERS-CoV to inhibit IFN production
[3, 22, 23].
CoV accessory proteins are not required for viral replication in cell culture although poten-
tially contribute to pathogenesis in vivo, possibly by interfering with the innate immune
response. In contrast to essential viral proteins, which are conserved across the CoV family,
the accessory proteins show high diversity among CoV genera. In particular, the 4b protein is
specific for MERS-CoV and does not show significant homology to other CoV accessory pro-
teins, with the exception of two related bat CoVs HKU4 and HKU5 (homology at the amino
acid level lower than 30%) and hedgehog CoVs included within the same lineage C of the
genus Betacoronavirus [24–26]. No significant homology to other viral or mammalian proteins
was found in protein databases.
Here we demonstrate the role of the MERS-CoV accessory protein 4b during infection,
using recombinant viruses that either completely delete 4b or alter its ability to traffic to the
nucleus. We found that 4b was required to prevent a robust NF-κB dependent response during
infection of both Huh-7 and Calu-3 cells (S1 Fig and Fig 1C). This function required the NLS
sequences of 4b, as opposed to a previous report [10], in which overexpressed 4b proteins lack-
ing the NLS were still able to inhibit IFN-β induction and to a lesser extent NF-κB signaling.
Importantly, we found that the nuclear localization of 4b was associated with the cytoplasmic
retention of NF-κB (Fig 6) and consequently, with the repression of NF-κB-mediated expres-
sion of pro-inflammatory cytokines (Fig 3A and 3C). We also found that both in isolation and
during infection, 4b interacted with α-karyopherin proteins in an NLS-dependent manner.
Interestingly, 4b had a strong preference for binding karyopherin-α4, which is also known to
translocate the NF-κB protein into the nucleus [18]. Interestingly, 4b binding to KPNA4 dur-
ing infection inhibited its interaction with NF-κB-p65 subunit (Fig 7). Thereby we propose a
model where 4b outcompetes NF-κB for KPNA4 binding and translocation into the nucleus
(Fig 8). Alternatively, other functions of 4b or additional MERS-CoV proteins might also con-
tribute to the NF-κB antagonism, as described for other coronaviruses, which include multiple
proteins that antagonize the host IFN and NF-κB responses [22, 27].
It has been reported that MERS-CoV 4b has phosphodiesterase (PDE) activity and antago-
nizes OAS-RNase L pathway by enzymatically degrading 2’,5’-oligoadenylate (2-5A), the acti-
vators of RNase L [28]. RNase L is an effector of the IFN-induced antiviral response and
cleaves viral and host single-stranded RNA, leading to cell death and preventing viral replica-
tion and spread. Nuclear localization of 4b is exceptional among the other known viral PDEs,
found in the cytoplasm. However, in the context of MHV infection, minor expression levels
of MERS-CoV 4b in the cytoplasm are sufficient to prevent RNase L activation and, in fact,
removal of the NLS did not improve RNase L antagonism. The relevance of 4b PDE activity to
promote MERS-CoV replication requires further confirmation in appropriate cell types. Our
results here and this previous study [28] suggest that 4b protein would provide MERS-CoV
with multiple mechanisms for evasion of innate immunity, such as the repression of the NF-
κB-mediated response and the inhibition of RNase L activation.
Although CoVs are cytoplasmic viruses, they do interact with the nucleus in diverse ways
including relocation to the nucleus of specific viral proteins and the disruption of host nuclear
transport [29]. This interaction can be beneficial either for viral replication or for the antago-
nism of host antiviral response. Some CoV genus-specific proteins, such as MERS-CoV 4b and
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SARS-CoV 3b, localize to the nucleus [10, 12, 20, 30], although their precise effect on host
nuclear processes is still unknown. The nucleocapsid (N) and nsp1 proteins have also been
detected in the nucleus, although this is not a conserved property in all CoVs. N protein
nuclear localization has been related to cell cycle arrest and recruitment to the cytoplasm of
nuclear proteins involved in viral RNA synthesis [29, 31]. The presence in the nucleus of
MERS-CoV nsp1 has been involved in the selective inhibition of nuclear-transcribed mRNA
expression [32], while porcine epidemic diarrhea virus (PEDV) nsp1 mediates the degradation
of CREB-binding protein in the nucleus, thus suppressing IFN I production [33]. CoV nsp1
and SARS-CoV ORF 3b proteins are sufficiently small to diffuse passively through the nuclear
pore complex [30, 32]. In contrast, nuclear import of larger proteins such as N and MERS-CoV
4b require host transporters and is mediated by NLS sequences [34].
Interference with the nuclear import machinery is a common viral strategy to evade the
innate immune response. Viruses have evolved different mechanisms to subvert nucleo-cyto-
plasmic transport by targeting soluble transport receptors such as karyopherins as well as com-
ponents of the nuclear pore complexes (NPC). Viruses with a nuclear stage, such as DNA
viruses and some RNA viruses, promote nuclear import of viral genome and proteins by
Fig 8. Proposed mechanism of 4b action in MERS-CoV infection. In WT MERS-CoV infection, 4b protein with an
intact NLS binds KPNA4 for nuclear translocation thereby outcompeting NF-κB binding to KPNA4, which retains
NF-κB in the cytoplasm and inhibits the expression of NF-κB-dependent pro-inflammatory cytokines. In contrast, in
the absence of 4b (MERS-CoV-Δ4b) or in the presence of cytoplasmic 4b NLS-mutants (MERS-CoV-4b-mNLS),
which do not bind KPNA4, NF-κB is imported into the nucleus by KPNA4, where it binds to DNA κB sites to promote
the expression of pro-inflammatory cytokines (TNF-α, IL-6 and IL-8).
https://doi.org/10.1371/journal.ppat.1006838.g008
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altering the NPC [35], which leads to a general inhibition of host nucleo-cytoplasmic traffick-
ing. Herpes simplex virus ICP27 protein interacts with the nucleoporin Nup62, an structural
component of the NPC, leading to the inhibition of nucleo-cytoplasmic transport pathways
mediated by transportin or importins [36]. Similarly, the Epstein-Barr virus (EBV) BGLF4
kinase interacts with the nucleoporins Nup62 and Nup153 inhibiting canonical NLS-mediated
nuclear import while promoting the nuclear import of non-NLS-containing EBV lytic proteins
[37].
Cytoplasmic viruses also share similar strategies to inhibit nuclear import of signals
required for host immune defenses. SARS-CoV ORF6 retains KPNA2 and karyopherin-β in
the cytoplasm, thus preventing STAT1 nuclear import and antagonizing IFN signaling path-
ways [38–40]. A similar mechanism of inhibition has also been described for Ebola virus VP24
[41]. Enterovirus 71 (EV71) infection suppresses IFN responses by inhibiting STAT1/2 nuclear
transport through the induction of caspase-3-dependent degradation of KPNA1 [42]. Poliovi-
rus and rhinovirus infection induce proteolysis of the NPC components Nup153 and p62,
leading to a general inhibition of nuclear import [43, 44]. The association of viral proteins with
the host nuclear import pathway confirms its relevance in virus-host interactions, regulating
innate immunity and cellular responses to infection.
NF-κB is a critical factor for the up regulation of innate immunity and inflammation in
response to viral infections [4]. Therefore, viruses in diverse families have evolved a variety of
mechanisms to target nuclear transport of the NF-κB complex and thereby inhibit its activa-
tion. The nucleocapsid protein of Hantaan virus inhibits NF-κB activation by limiting p65
nuclear translocation, as shown in overexpression experiments [45], presumably by its interac-
tion with importin-α through a putative NLS. Japanese encephalitis virus NS5 competitively
inhibits NF-κB nuclear translocation by binding to KPNA2, 3 and 4, presumably through two
NLSs within NS5, which surprisingly does not accumulate in the nucleus [46]. Alternatively,
viral proteins such as Herpes simplex virus 1 UL24 inhibit the NF-κB pathway by binding p65
and p50 subunits and preventing their nuclear translocation [47].
In CoVs, there is also evidence supporting the relevance of the NF-κB pathway in pathogen-
esis. Increased NF-κB activation is a determinant of the exacerbated lung inflammatory
pathology caused by SARS-CoV infection [6]. Consequently, inhibition of NF-κB signaling
significantly reduced pulmonary inflammation and increased survival of SARS-CoV-infected
mice [5]. Dual regulation of NF-κB signaling during HCoV-229E infection has been described,
consisting in the simultaneous induction of the NF-κB pathway, which has a pro-viral effect,
and the restriction of the NF-κB response to limit transcription of pro-inflammatory and
other potentially antiviral host cell genes [48]. Here, our results with MERS-CoV 4b protein
are compatible with this concept of repression of the NF-κB-mediated pro-inflammatory
response during CoV infection.
Viral antagonists of the innate immune response contribute to the pathogenic potential of
coronaviruses in vivo [27, 49]. In particular, inhibition of nuclear import by SARS-CoV ORF6
has been shown to mediate pleiotropic alterations in host gene expression during infection [50]
that enhance viral pathogenesis in vivo [51]. In addition, MERS-CoV 4b protein expressed in
mice by chimeric MHV viruses acted as an RNase L antagonist contributing to pathogenesis in
vivo [28]. From this study and from the results reported here, it might be speculated that deletion
of MERS-CoV 4b protein would enhance the host antiviral response leading to virus attenuation
in vivo. However, the possibility that the increased NF-κB-response induced by 4b deletion could
result in lung inflammatory pathology [5] cannot be excluded until in vivo studies are performed.
Humanized mice (hDPP4-KI) infected with mouse-adapted MERS-CoV develop lethal dis-
ease and will be useful for determining the role of the 4b protein in pathogenesis. Human and
mouse KPNA4 proteins share 99% amino acid identity, including binding sites of NLSs
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present in NF-κB p65 and p50 subunits [18]. Consequently, the interaction between MERS-
CoV 4b and human KPNA4 reported here is expected to function similarly in mouse cells,
inhibiting NF-κB nuclear translocation in the MERS-CoV mouse model.
In one study, no differences in lethality were observed in human DPP4 knockin mice infected
with mouse adapted MERS-CoV isolates differing in the presence or absence of ORF3-4a-4b
accessory genes in addition to other non-synonymous mutations [52]. In a second study, two
adapted viral clones with large deletions in ORF4b, in addition to other missense mutations
throughout the genome, caused increased lung inflammation and mouse weight losses [53]. How-
ever, none of these studies used congenic strains of virus solely differing in 4b expression. Infec-
tion with such strains will provide insight into the role of 4b in the context of severe infection.
Materials and methods
Cells and viruses
Baby hamster kidney cells (BHK-21) were obtained from American Type Culture Collection
(ATCC CCL-10). Human liver-derived Huh-7 cells were kindly provided by R. Bartenschlager
(University of Heidelberg, Germany). Cells were grown in BioWhittaker (Lonza) or Dulbec-
co’s modified Eagle medium (DMEM) with 2% glutamine, 1% non-essential amino acids
(Sigma) and 5% (BHK-21) or 8% (Huh-7) fetal bovine serum (FBS) (HyClone, ThermoFisher).
The bronchial epithelial cell line Calu-3 2B4 [54] was kindly provided by CT Tseng (University
of Texas Medical Branch, USA). Calu-3 cells were grown in BioWhittaker (Lonza) 1 g/L glu-
cose medium with 2% glutamine, 1% non-essential amino acids (Sigma) and 15% fetal bovine
serum (FBS) (HyClone, ThermoFisher).
Virus titers were determined on Huh-7 cells following standard procedures and using
closed flasks or plates sealed in plastic bags. For plaque assays, infected cells were overlaid with
DMEM containing 0.6% low-melting agarose and 2% FBS, and at 72 hpi, cells were fixed with
10% formaldehyde and stained with 0.1% crystal violet. All work with MERS-CoV infectious
viruses was performed in biosafety level 3 facilities at CNB-CSIC or the University of Iowa
according to the guidelines set forth by each institution.
Bacteria strain and plasmids
E. coli DH10B (Gibco/BRL) cells were transformed by electroporation using a MicroPulser
unit (Bio-Rad) according to the manufacturer’s instructions and grown on antibiotic-selective
LB medium.
MERS-CoV ORF4a-HA and ORF4b-HA nucleotide sequences were synthesized and cloned
into pUC57 (GenScript). They were then PCR amplified, restriction digested and ligated into
the pLKO plasmid. A pLKO ORF4b-3XFLAG plasmid was made by creating a PCR product
replacing the HA tag with a 3XFLAG tag. This PCR product was restriction digested and
ligated back into the pLKO plasmid. The resulting constructs were confirmed by restriction
digest, PCR, and direct sequencing. The sMacro and GFP pcDNA3 plasmids were previously
described [55]. The NSP15-3XFLAG plasmid was a generous gift of Michael Buchmeier (Uni-
versity of California-Irvine), and the KPNA-FLAG plasmids were a generous gift of Megan
Shaw (Mount Sinai Medical Center). Cells were transfected using Polyjet (Amgen) or Lipofec-
tamine 2000 (Fisher Scientific) as per the manufacturer’s instructions.
Construction of deletion mutants MERS-CoV-Δ4a and MERS-CoV-Δ4b
Genes 4a and 4b were deleted from the MERS-CoV infectious cDNA clone by PCR-directed
mutagenesis. The plasmid pBAC-MERSFL was used as the template for amplification of
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overlapping PCR fragments with oligonucleotides MERS-del4a-26022-VS (50-CTATGGATTA
CGTGTCTCTGCTTACAGCTATCCTTTGCTGGTTATACTGAATCT-30) and MERS-del4a-
26022-RS (5’-AGATTCAGTATAACCAGCAAAGGATAGCTGTAAGCAGAGACACGTAA
TCCATAG -3’) for 4a deletion or MERS-del4b-26811-VS (5’-GCGAGGAAGAGGAGCCATT
CTCCAACTAAGTAATAAACAAATTGTTCATTCTTATCCC-3’) and MERS-del4b-26811-
RS (5’-GGGATAAGAATGAACAATTTGTTTATTACTTAGTTGGAGAATGGCTCCTCT
TCCTCGC -3’) for 4b deletion. The final PCR product was amplified with external oligonucle-
otides SA25412-VS (5’-CTGCACTGGTTGTGGCAC-3’) and MERS-26970-Nhe RS (50 GCT
AAAGCAGCTACATAGCCGCTAGCAGGAATG 30; NheI is underlined), digested with PacI
and NheI, and cloned into the same restriction sites of pBAC-MERS-30 [8]. The PacI-RsrII
digestion products from plasmids pBAC-MERS-30-Δ4a and pBAC-MERS-30-Δ4b were cloned
into the same sites of pBAC-MERSFL (Fig 2A). pBAC-MERSFL-Δ4a included a deletion from
nucleotides 25,874 to 25,991 of the MERS-CoV genome, while the deletion in pBAC-MERSFL-
Δ4b extended from nucleotides 26,183 to 26,781. For all constructs, sequences were checked
after cloning by sequencing. Recombinant BACs were isolated and purified using a large-con-
struct kit (Qiagen), following the manufacturer’s specifications.
Construction of recombinant MERS-CoV genomes with mutated 4b NLSs
The complete sequence of 4a and 4b genes in the MERS-CoV infectious cDNA [8] was
replaced with chemically synthesized fragments (GeneArt, Invitrogen) introduced into
PacI-NheI sites (nt 25841 to 26945), including either the duplication of 4a/4b region alone or
in combination with NLS mutations. The resulting pBAC-MERS-CoV-DUP contained a
duplication of the last 189 nt of 4a gene, including the 4a/4b overlapping sequence and the pre-
ceding 4a 101 nt. Furthermore, three silent point mutations were introduced into 4a gene
(T26094C, T26109C and A26112C) to prevent premature translation initiations of 4b from the
sgmRNA 4ab. pBAC-MERS-DUP-mNLS-S1 included the 4b NLS-S1 (aa 22–24) mutated to
alanine (RKR! AAA) in a sequence context identical to the control pBAC-MERS-CoV-DUP,
while pBAC-MERS-DUP-mNLS-S2 included alanine mutations in 4b NLS-S2 (aa 36–38) and
two intermediate Lys residues, (aa 30–31) (KRR! AAA and KK! AA, respectively). The
genetic integrity of the cDNAs was verified by restriction analysis and sequencing.
Recovery of recombinant viruses from the cDNA clones
To recover infectious viruses, BHK-21 cells were transfected with the infectious cDNA clones
using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s specifications. At 6 h
post-transfection, cells were trypsinized, plated over a confluent monolayer of Huh-7 cells, and
incubated at 37˚C for 72 h. The cell supernatants were harvested and passaged once on fresh
Huh-7 cells and then virus titers were determined. The genetic stability of rescued viruses was
verified by sequencing the genomic region comprising the 4a and 4b genes using RT-PCR.
Growth kinetics of recombinant MERS-CoVs
Confluent monolayers of Huh-7 or Calu-3 cells were infected at a MOI of 0.1 and 0.001 PFU/
cell. Cell supernatants were collected at 24, 48 and 72 hpi and virus titers were determined as
described above.
Analysis of gene expression by RT-qPCR
Total intracellular RNA was extracted from transfected or infected cells with the RNeasy mini-
prep kit (Qiagen) according to the manufacturer’s specifications. Total cDNA was synthesized
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with random hexamers from 100 ng of total RNA using a High-Capacity cDNA reverse tran-
scription kit (Invitrogen). For qPCR assays, specific TaqMan assays (Apply Biosystems) for
TNF-α (Hs99999043_m1); IL-6 (Hs00985641_m1); IL-8 (Hs99999034_m1); IFN-β
(Hs02621180_s1) and hydroxymethylbilane synthase (HMBS, Hs00609297_m1, as an endoge-
nous control) were used. MERS-CoV genomic RNA (gRNA) synthesis was analyzed using a
custom TaqMan assay as described [8]. Data acquisition, analysis and normalization were per-
formed as described [8]. Two micrograms of polyinosinic-polycytidylic acid [Poly(I:C)] were
used for reverse transfection of cells with 12 μg of Lipofectamine 2000 (Invitrogen), as recom-
mended by the manufacturer. The relative quantifications were performed using the 2-ΔΔCt
method [56].
Generation of polyclonal antisera specific for MERS-CoV 4a and 4b
proteins
Rabbit polyclonal antisera (pAb) specific for MERS-CoV 4a and 4b proteins were ordered
from BioGenes (Germany). In brief, rabbits were immunized with synthetic peptides PDG
CSLYLRHSSLFAQSEEEEPFSN (25 C-terminal residues of protein 4a) and SIRSSNQGNKQ
IVHSYPILHHPGF (24 C-terminal residues of protein 4b, as described) [10], according to
standard protocols. The specificity of the antisera was assessed by Western-blot and immuno-
fluorescence microscopy of MERS-CoV-infected Huh-7 cells, with pre-immune sera and
mock-infected cells as negative controls.
Immunoprecipitation
At either 48 hours post-transfection or 20 hours post-infection, Huh-7 cells were collected and
pelleted by low speed centrifugation prior to lysis. Cell pellets were lysed with IP buffer (0.5–
2% NP-40, 300 mM NaCl, 5% glycerol, and 50 mM Tris pH 8.0), with protease/phosphatase
inhibitor cocktails (Roche), PMSF, and a universal nuclease (ThermoFisher Scientific) for 1
hour at 4ºC. Next, nuclei were pelleted by centrifugation (16,000 x g for 15 min at 4ºC). One
aliquot of cell lysate was saved as the input control and boiled in SDS sample buffer in the pres-
ence of sample reducing agent. Supernatants were then applied to FLAG antibody conjugated
magnetic beads (Sigma Aldrich #M8823) and were mixed for 2 hours-overnight at 4ºC. Beads
were washed with TBS-Tween before elution with FLAG peptide (1 μg/ml) for 1 hour and
then boiled in SDS sample buffer in the presence of sample reducing agent.
For mass spectrometry analysis, proteins precipitated by anti-FLAG antibody were resolved
on a NuPAGE 4–12% gradient gel (Novex) and subsequently stained using a Silver Stain kit
(Pierce) according to the manufacturer’s instructions. Protein bands unique to the 4b-3XFLAG
transfected sample were extracted. In addition, gel bands from the NSP15-3XFLAG sample
with migrating positions corresponding to those of 4b-3XFLAG specific bands were also
extracted as negative controls. Extracted gel samples were submitted to the Keck Mass Spec-
trometry and Proteomics Facility (School of Medicine, Yale University) for liquid chromatogra-
phy (LC)-mass spectrometry analysis for protein identification.
Nuclear and cytoplasmic fractionation
Whole protein extracts were prepared from Huh-7 or Calu-3 cells in loading buffer [0.1 M
Tris-HCl, pH 6.8; 20% glycerol; 4% w/v sodium dodecyl-sulfate (SDS); 0.2% bromophenol
blue and 0.05% β-mercaptoethanol]. Nuclear and cytoplasmic fractions of Huh-7 or Calu-3
cells were prepared using a protocol adapted from [57]. Briefly, cell monolayers were washed
three times with PBS, collected and resuspended in lysis buffer [0.1% IGEPAL CA-630
(Sigma-Aldrich) in PBS]. Extracts were centrifuged at 1000 x g for 1 min to recover the
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cytoplasmic fraction in the supernatant and the nuclei in the pellet. The cytosolic fraction was
removed and mixed with Laemmli sample buffer 1:1, while the pellet was resuspended in PBS
with 0.1% IGEPAL and centrifuged at 1000 x g for 1 min. The supernatant was discarded and
the pellet, designated as nuclear fraction, was treated with DNase (Roche) at 37ºC for 1 hour
and then mixed 1:1 with Laemmli sample buffer.
Western blotting
Cell extracts or IP elutions were lysed in sample buffer containing SDS, protease and phospha-
tase inhibitors (Roche), β-mercaptoethanol, and a universal nuclease (Fisher Scientific). Pro-
teins were resolved on an SDS polyacrylamide gel, transferred to a polyvinylidene difluoride
(PVDF) or nitrocellulose membrane, hybridized with a primary antibody, reacted with either
HRP or infrared (IR) dye-conjugated secondary antibody, visualized using chemiluminescent
substrate (Bio-Rad) or a Li-COR Odyssey Imager (Li-COR), and analyzed using Image Studio
software. Primary antibodies used for immunoblotting included anti-FLAG monoclonal anti-
body (Sigma-Aldrich #F1804); anti-HA monoclonal antibody (Biolegend #901513); anti-
MERS-CoV 4b polyclonal antibody and anti-MERS-CoV 4a polyclonal antibodies (this study);
anti-KPNA3 and anti-KPNA4 polyclonal antibodies (Thermo Scientific #PA5-18238/PA5-
21033); anti-MERS-CoV N protein [8]; anti-histone H3 (Cell Signaling #9715); anti-p65 (Cell
Signaling #6956); anti-GAPDH mAb (Cell Signaling #5174). Secondary antibodies used
included horseradish peroxidase-conjugated anti-rabbit or anti-mouse (Sigma #A0545/A0168)
antibodies; or IR conjugated anti-rabbit or anti-mouse (Li-COR, #926-68071/926-32210)
antibodies.
Analysis of the subcellular localization of 4a, 4b and NF-κB proteins by
confocal microscopy
Huh-7 or Calu-3 cells were grown to 95% confluence on sterile glass coverslips and infected
with MERS-CoV at a MOI of 0.1 PFU/cell. At 24 hpi, cells were fixed and the virus was fully
inactivated by incubating with 4% paraformaldehyde in PBS at RT for 45 min. Cells were per-
meabilized with methanol at −20˚C for 10 min and blocked with 10% FBS in PBS at RT for 1
h. MERS-CoV 4a and 4b proteins were detected with the specific pAbs described above.
dsRNA was detected with J2 mAb (SCICONS) and NF-κB was detected with anti-p65 (Cell
Signaling #6956) diluted in PBS 5% FBS. Coverslips were washed 4 times with PBS and incu-
bated with secondary antibodies conjugated to Alexa Fluor 488 or 594 (Invitrogen) diluted
1:500 in 5% FBS in PBS at RT for 45 min. Nuclei were stained using DAPI (40,6-diamidino-
2-phenylindole) diluted 1:200 in PBS. Finally, coverslips were mounted in ProLong Gold anti-
fade reagent (Invitrogen) and analyzed on a Leica SP8 confocal microscope. Images were
acquired with the same instrument settings and analyzed with Leica software.
Supporting information
S1 Fig. Cytokine response of Huh-7 cells infected with MERS-CoV-Δ3, Δ4ab, Δ5 and WT
virus. Huh-7 cells were either transfected with 2 μg poly(I:C) or infected (MOI = 1 PFU/cell)
and total RNA was collected at 16 hpt or 24 hpi, respectively. IFN-β, IL-6, IL-8 and TNF-α
mRNA expression levels were quantified by RT-qPCR and related to those in WT-infected
cells, using the ΔΔCt method for calculation and HMBS as a reference endogenous gene.
Shown are means with standard deviations, which were analyzed using an unpaired t-test
against the wild-type (ns, not significant; , p<0.01; , p<0.001).
(TIF)
NF-κB inhibition by MERS-CoV 4b protein during infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006838 January 25, 2018 20 / 25
S2 Fig. Expression and localization of 4a and 4b proteins during infection with MERS-CoV-
Δ4a and Δ4b deletion mutants. Huh-7 cells were mock-infected or infected with the WT, Δ4ab,
Δ4a or Δ4b deletion mutants (MOI = 0.1 PFU/cell). At 24 hpi, cell lysates were analyzed by West-
ern blot and detected with the indicated antibodies (A). MERS-CoV protein N was used as a pos-
itive control for infection. At 24 hpi cells were fixed and stained with specific antibodies against
4a (B) or 4b (C) (green) and dsRNA (red). Cell nuclei were stained with DAPI (blue).
(TIF)
S3 Fig. Characterization of MERS-CoV-4b-NLS mutants. Huh-7 cells were mock-infected
or infected with the WT or 4b-NLS mutants (MOI of 0.1 PFU/cell). At 24 hpi, cell lysates were
analyzed by Western blot (A) with the indicated antibodies; or cells were fixed and stained
with specific antibodies (B) against 4a (green) and dsRNA (red). Cell nuclei were stained with
DAPI (blue). (C) Growth kinetics of MERS-CoV-4b-NLS mutants at a MOI 0.001 PFU/cell.
Supernatants were collected at 24, 48 and 72 hpi and titrated by plaque assay.
(TIF)
S4 Fig. IκBα degradation kinetics and NF-κB activation during infection with 4b-NLS
mutants. (A) Huh-7 cells were mock-infected or infected with WT, Δ4b or 4b-NLS mutants
(MOI = 1 PFU/ml). At 14 hpi, cell supernatant was replaced by fresh medium containing
TNF-α (50 ng/ml). After the indicated times of treatment, cell lysates were prepared for immu-
noblotting with anti-IκBα antibodies. Actin was used as a loading control. (B) Huh-7 cells
were mock-infected or infected with WT virus (MOI = 1 PFU/cell). After indicated times, cell
lysates were collected for Western blot analysis of 4b protein expression. N protein was used as
a control. (C) Huh-7 cells were mock-infected or infected with WT or Δ4b mutant (MOI = 1
PFU/ml). At 14 hpi, cells were treated with TNF-α (50 ng/ml) for 30 min. Total RNA was
extracted and mRNA expression levels of TNF-α, IL-6 and IL-8 were quantified by RT-qPCR
and compared to those in untreated WT-infected cells, using the ΔΔCt method and HMBS as
a reference endogenous gene. Error bars represent SD.
(TIF)
S5 Fig. Mass spectrometry analysis of MERS-CoV 4b protein interacting partners. KPNA3
and KPNA4 peptides specifically identified by mass spec from 4b-FLAG Co-IP samples are listed.
(TIF)
S6 Fig. Quantification of 4b and NF-κB bands from Western blots in Fig 6. Protein 4b and
NF-κB band intensities in cytoplasmic or nuclear fractions of Huh-7 (A) or Calu-3 (B) cells
were normalized to GAPDH or H3 levels, respectively. The normalized intensity of 4b or p65
in the mock-infected samples was set to 1. These data represent the average results of 2 inde-
pendent experiments. Shown are means with standard deviations, which were analyzed using
an unpaired t-test against the wild-type (, p<0.01).
(TIF)
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